Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

TSXVXBOTBullishCorporate Developmentsnews

High materiality7/10

Realbotix advances Nasdaq uplisting via Onconetix merger and deployments

Aug 12, 2026, 7:35 AM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

Key catalyst is the Nasdaq uplisting via a reverse merger, which could unlock liquidity and attract institutional interest; deployment momentum and long-run AI/robotics opportunities further support upside, despite near-term margin and revenue headwinds observed in the results.

AI summary

What happened, with direct paths to the underlying reporting

Realbotix reports Q3-2026 results with revenue declines amid strategic repositioning and crypto wind-down, yet highlights deployment momentum across Realbotix LLC and Intima LLC and plans for Echo Generation One. The company aims to list Realbotix LLC on Nasdaq via a reverse merger with Onconetix in Q4-2026, which could unlock liquidity and broaden investor access as IG firms scale embedded AI robotics.

Q3-2026 revenue $354k; nine months $932k, down YoY.
Intima LLC revenue $222k (3Q) and $746k (9M); Realbotix LLC $132k (3Q) and $184k (9M).
Gross margins 24.4% (3Q) and 21.0% (9M); prior-year 37.1% and 43.5%.
Onconetix merger targets Nasdaq listing; closing anticipated Q4-2026.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.